Rossini et al. measured serum SOST levels by ELISA (Biomedica Medizinprodukte GmbH & Co. KG, Vienna, Austria) in a group of 22 ISM patients (mean duration of disease: 10.9 ± 9.3 years) with osteopenia or osteoporosis. This evidence concerns the gene SOST and Osteopenia.